Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced
ALK
+
NSCLC
: A multicenter retrospective analysis in China
Thoracic Cancer（2021）
关键词
Alectinib,ALK+ NSCLC,Crizotinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要